Mono Pharmacare Ltd

Mono Pharmacare Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Mono Pharmacare Ltd

₹ 24.0 -4.00%
16 Jun - close price
monopharmacareltd.com NSE - SME: MONOPHARMA
About

Incorporated in 1994, Mono Pharmacare Ltd is in the business of distribution of Pharmaceutical items[1]

Key Points

Business Overview:[1]
MPL is a distributor and supplier of a wide array of pharmaceutical products and medicines. It offers
Health Care Products, Antibiotic medicines, Cough Cold Anti-Allergic medicines, Antifungal medicines, Nutraceutical medicines, Analgesic & Antipyretic medicines, Antacid
& Antiemetic medicines, Cardiac – Diabetic medicines, and Cosmo care products.

Website NSE - SM
  • Market Cap ₹ 42.4 Cr.
  • Current Price ₹ 24.0
  • High / Low ₹ 42.8 / 22.1
  • Stock P/E 13.7
  • Book Value ₹ 17.7
  • Dividend Yield 0.00 %
  • ROCE 10.4 %
  • ROE 10.4 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company's working capital requirements have reduced from 306 days to 110 days

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company might be capitalizing the interest cost
  • Earnings include an other income of Rs.2.54 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Half Yearly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Sep 2023 Mar 2024 Sep 2024 Mar 2025
21.96 34.60 36.12 44.38 38.26
20.62 32.56 35.70 41.73 38.34
Operating Profit 1.34 2.04 0.42 2.65 -0.08
OPM % 6.10% 5.90% 1.16% 5.97% -0.21%
0.19 0.78 0.92 0.78 1.75
Interest 0.56 0.58 0.64 0.59 0.65
Depreciation 0.04 0.04 0.04 0.03 0.05
Profit before tax 0.93 2.20 0.66 2.81 0.97
Tax % 31.18% 15.00% 12.12% 18.15% 17.53%
0.64 1.87 0.58 2.29 0.80
EPS in Rs 0.52 1.06 0.33 1.30 0.45
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Mar 2024 Mar 2025
13.92 70.72 82.64
13.05 68.19 80.08
Operating Profit 0.87 2.53 2.56
OPM % 6.25% 3.58% 3.10%
0.20 1.69 2.54
Interest 0.38 1.28 1.24
Depreciation 0.02 0.08 0.08
Profit before tax 0.67 2.86 3.78
Tax % 19.40% 14.69% 18.25%
0.54 2.44 3.09
EPS in Rs 0.44 1.38 1.75
Dividend Payout % 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 17%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 26%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -41%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 10%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Mar 2024 Mar 2025
Equity Capital 12.37 17.67 17.67
Reserves 1.03 10.44 13.53
12.51 13.27 23.70
3.15 4.02 11.17
Total Liabilities 29.06 45.40 66.07
0.19 0.14 0.22
CWIP 0.00 0.00 0.02
Investments 1.97 3.59 0.00
26.90 41.67 65.83
Total Assets 29.06 45.40 66.07

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Mar 2024 Mar 2025
-13.49 -10.32 1.29
-2.18 -1.66 -7.43
15.90 12.00 8.02
Net Cash Flow 0.23 0.02 1.88

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Mar 2024 Mar 2025
Debtor Days 211.87 90.01 0.00
Inventory Days 466.39 118.95 136.54
Days Payable 64.21 16.55 45.79
Cash Conversion Cycle 614.04 192.41 90.75
Working Capital Days 614.89 193.03 109.71
ROCE % 12.33% 10.43%

Shareholding Pattern

Numbers in percentages

1 Recently
Sep 2023Dec 2023Mar 2024Sep 2024Mar 2025
56.72% 56.72% 56.72% 56.72% 56.72%
43.28% 43.27% 43.28% 43.28% 43.28%
No. of Shareholders 621528418463478

Documents

Announcements

Annual reports